FI3619204T3 - Yhdisteitä hengitystiesairauksien hoitoon - Google Patents
Yhdisteitä hengitystiesairauksien hoitoonInfo
- Publication number
- FI3619204T3 FI3619204T3 FIEP18795097.7T FI18795097T FI3619204T3 FI 3619204 T3 FI3619204 T3 FI 3619204T3 FI 18795097 T FI18795097 T FI 18795097T FI 3619204 T3 FI3619204 T3 FI 3619204T3
- Authority
- FI
- Finland
- Prior art keywords
- polymorph
- solvate
- salt
- compound
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2017901611A AU2017901611A0 (en) | 2017-05-03 | Compounds for the treatment of respiratory diseases | |
| AU2017901647A AU2017901647A0 (en) | 2017-05-05 | Compounds for the treatment of respiratory diseases | |
| PCT/AU2018/050404 WO2018201192A1 (en) | 2017-05-03 | 2018-05-03 | Compounds for the treatment of respiratory diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI3619204T3 true FI3619204T3 (fi) | 2025-11-06 |
Family
ID=64015663
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FIEP18795097.7T FI3619204T3 (fi) | 2017-05-03 | 2018-05-03 | Yhdisteitä hengitystiesairauksien hoitoon |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20200079757A1 (https=) |
| EP (1) | EP3619204B1 (https=) |
| JP (2) | JP7788128B2 (https=) |
| CN (1) | CN110753688A (https=) |
| AU (3) | AU2018262108A1 (https=) |
| ES (1) | ES3049333T3 (https=) |
| FI (1) | FI3619204T3 (https=) |
| PT (1) | PT3619204T (https=) |
| WO (1) | WO2018201192A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107847480B (zh) | 2015-03-23 | 2021-06-25 | 墨尔本大学 | 呼吸性疾病的治疗 |
| JP7575099B2 (ja) * | 2018-11-07 | 2024-10-29 | ティアンリ バイオテック プロプライエタリ リミテッド | 呼吸器疾患の処理のための新規な化合物 |
| CN110452880B (zh) * | 2019-09-09 | 2021-09-21 | 温州医科大学附属第一医院 | 急性肺损伤细胞模型的制备方法及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5593992A (en) * | 1993-07-16 | 1997-01-14 | Smithkline Beecham Corporation | Compounds |
| IL110296A (en) * | 1993-07-16 | 1999-12-31 | Smithkline Beecham Corp | Imidazole compounds process for their preparation and pharmaceutical compositions containing them |
| US5593991A (en) * | 1993-07-16 | 1997-01-14 | Adams; Jerry L. | Imidazole compounds, use and process of making |
| IL118544A (en) * | 1995-06-07 | 2001-08-08 | Smithkline Beecham Corp | History of imidazole, the process for their preparation and the pharmaceutical preparations containing them |
| WO1999032121A1 (en) * | 1997-12-19 | 1999-07-01 | Smithkline Beecham Corporation | Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses |
| SI2493876T1 (sl) * | 2009-10-28 | 2014-04-30 | Pfizer Inc. | Derivati imidazola kot inhibitorji kazein-kinaze |
| CZ2012538A3 (cs) * | 2012-08-08 | 2014-02-19 | Masarykova Univerzita | Inhibitory pro léčbu B-buněčné chronické lymfocytární leukémie |
| CN107847480B (zh) * | 2015-03-23 | 2021-06-25 | 墨尔本大学 | 呼吸性疾病的治疗 |
-
2018
- 2018-05-03 PT PT187950977T patent/PT3619204T/pt unknown
- 2018-05-03 EP EP18795097.7A patent/EP3619204B1/en active Active
- 2018-05-03 AU AU2018262108A patent/AU2018262108A1/en not_active Abandoned
- 2018-05-03 WO PCT/AU2018/050404 patent/WO2018201192A1/en not_active Ceased
- 2018-05-03 FI FIEP18795097.7T patent/FI3619204T3/fi active
- 2018-05-03 ES ES18795097T patent/ES3049333T3/es active Active
- 2018-05-03 JP JP2019560254A patent/JP7788128B2/ja active Active
- 2018-05-03 CN CN201880039084.6A patent/CN110753688A/zh active Pending
- 2018-05-03 US US16/610,168 patent/US20200079757A1/en not_active Abandoned
-
2022
- 2022-03-09 US US17/690,855 patent/US20220380343A1/en active Pending
- 2022-04-27 AU AU2022202774A patent/AU2022202774A1/en not_active Abandoned
-
2023
- 2023-06-21 JP JP2023101906A patent/JP2023134493A/ja not_active Withdrawn
-
2024
- 2024-01-29 AU AU2024200521A patent/AU2024200521B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PT3619204T (pt) | 2025-10-29 |
| EP3619204A1 (en) | 2020-03-11 |
| JP2020518621A (ja) | 2020-06-25 |
| EP3619204B1 (en) | 2025-10-01 |
| ES3049333T3 (en) | 2025-12-16 |
| EP3619204A4 (en) | 2021-03-24 |
| US20220380343A1 (en) | 2022-12-01 |
| US20200079757A1 (en) | 2020-03-12 |
| AU2018262108A1 (en) | 2019-11-21 |
| AU2022202774A1 (en) | 2022-05-19 |
| CN110753688A (zh) | 2020-02-04 |
| JP2023134493A (ja) | 2023-09-27 |
| JP7788128B2 (ja) | 2025-12-18 |
| AU2024200521B2 (en) | 2025-10-02 |
| WO2018201192A1 (en) | 2018-11-08 |
| AU2024200521A1 (en) | 2024-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2023000196A1 (es) | Compuestos de tetrahidropirazolo-pirazinil-dihidroimidazolona o tetrahidropirazolo-piridinil-dihidroimidazolona y métodos de uso de los mismos | |
| DOP2020000037A (es) | Derivados de 3-(1-oxoisoindolin-2-il)piperidina-2,6-diona y usos de los mismos | |
| ECSP24026637A (es) | Derivados de 3-(5-hidroxi-1-oxoisoindolin-2-il)piperidina-2,6-diona | |
| MX2021000310A (es) | Derivados de 3-(5-amino-1-oxoisoindolin-2-il)piperidin-2,6-diona y su uso en el tratamiento de las enfermedades que dependen de la familia de dedo de zinc ikaros (ikzf2). | |
| PH12019500395A1 (en) | Amino-pyrrolopyrimidinone compounds and methods of use thereof | |
| JP2019504050A5 (https=) | ||
| MX2020005874A (es) | Acidos carbamoil ciclohexilicos n-enlazados a pirazol como antagonistas de receptores del acido lisofosfatidico (lpa). | |
| EP4467549A3 (en) | Intermediates of n-(3-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)benzamide derivatives | |
| ES2655091T3 (es) | Derivados del ácido pirrolidíncarboxílico como agonistas del receptor 43 acoplado a proteína G (GPR43), composición farmacéutica y métodos para su uso en el tratamiento de trastornos metabólicos | |
| JP2016506369A5 (https=) | ||
| AR073209A1 (es) | Tienopirimidinas utiles para la profilaxis y/o tratamiento de enfermedades influenciadas por la inhibicion de quinasas mnk1 y/o mnk2 ,tales como enfermedades metabolicas y trastornos inflamatorios,y composiciones farmaceuticas que las contienen. | |
| JP2017501237A5 (https=) | ||
| PE20141148A1 (es) | Mesilato de n-[5-(aminosulfonil)-4 metil-1-3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)fenil]acetamida monohidrato | |
| HRP20210847T1 (hr) | Supstituirani derivati indola kao inhibitori replikacije denga virusa | |
| FI3619204T3 (fi) | Yhdisteitä hengitystiesairauksien hoitoon | |
| AR062394A1 (es) | Uso de compuestos y derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis | |
| FI3546462T3 (fi) | Uusi oksoisokinoliinijohdannainen | |
| IL276711B2 (en) | Arginase inhibitors and methods of use thereof | |
| EA202190395A1 (ru) | Замещенные гетероарилом сульфонамидные соединения и их применение в качестве терапевтических средств | |
| EA201590021A1 (ru) | Новые замещенные производные 1,3-дигидро-2h-бензимидазол-2-она, замещенные гетероциклами, в качестве противовирусных средств против респираторного синцитиального вируса | |
| RU2019123404A (ru) | Производное пиримидина | |
| MX2020010866A (es) | Compuestos novedosos utiles como abridores del canal de potasio. | |
| CY1120530T1 (el) | Απο του στοματος χορηγησιμη φαρμακευτικη συνθεση | |
| RU2017117566A (ru) | Активатор kcnq2-5 каналов | |
| MX2022003617A (es) | Derivados heterociclicos, composiciones farmaceuticas y su uso en el tratamiento o mejora del cancer. |